|Understanding the Issue:
NAMI Statement on MEDPAC
NAMI Comments on the Medicare Mental Health Inpatient Equity Act (HR 6143)
Read submitted comments submitted by NAMI to Representative Paul Tonko in support of the Medicare Mental Health Inpatient Equity Act (HR 6143)
Medicare Part D Benefit Update: 2011 Open Enrollment Period Set to Begin
Open enrollment for the Part D prescription drug benefit program will begin on November 15, 2010 and run through December 31, 2010.
Medicare Drug Benefit Update: 2010 Plan Year Enrollment Begins
This week marks the start of the open enrollment period for the Medicare Part D drug benefit for 2010. The "open season" period for 2010 drug plan enrollment runs through December 31.
NAMI Comments on Medicare Part D Regulations on Drug Formulary Coverage Rules
Read NAMI's comments on Federal regulations related to the Medicare Advantage and Medicare Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies.
NAMI's Letter of Support for HR 6331
Major Provisions in HR 6331 for Beneficiaries With Mental Illness
Learn more about critical provisions included in HR 6331 for Medicare beneficiaries living with serious mental illness.
Background Information on the Senate Finance Committee Medicare Package
The major focus of this legislation is an adjustment to the payment rates for physicians to avoid cuts that will occur in 2008 if Congress fails to act. This creates a unique opportunity to push for improvements to Medicare that NAMI has sought for years and to make progress in stopping regulations that would severely limit how Medicaid pays for important community-based services for people with mental illness.
Medication Access and Continuity Under Medicare Part D
An editorial by the American Psychiatric Association, commenting on a recent study of dual eligibles under Medicare Part D..
Medication Access and Continuity
A study released by the American Psychiatric Association on the experiences of dual-eligible psychiatric patients during the first four months of the Medicare prescription drug benefit.
U.S. Senate Takes Up Medicare Prescription Drug Legislation
On April 18, the Senate fell 5 votes short of cutting off debate on legislation to amend the Medicare prescription drug program to allow the Secretary of Health and Human Services (HHS) to negotiate directly with drug manufacturers. The legislation (S 3), would remove a provision in current law that bars the Secretary from negotiating to establish a uniform price and formulary structure for prescription drug coverage.
Medicare Answers are Just a Click Away
People are always looking for more information about Medicare, the federal health insurance program for older adults and people with disabilities. Now, you will no longer have to search further than our own website.
Medicare Part D: Transition Period Ends
Initial transition rules for the Medicare Part D drug benefit expired on March 31, allowing Prescription Drug Plans (PDPs) to begin imposing restrictions on access to some medications on their preferred drug lists (also known as formularies).
NAMI Comments on US Pharmacopeia Model Guidelines
The US Pharmacopeia (USP) recently published proposed revisions to the Model Guidelines for the Medicare drug benefit. These guidelines set forth the listings of therapeutic categories that most Medicare drug plans use to decide which medications are on their preferred drug lists.
Medicare Update: "Transition Plan" Guidance for Drug Coverage
The Centers for Medicare and Medicaid Services (CMS) released long anticipated guidance to Medicare prescription drug plans on their obligation to ensure a smooth transition for persons dually eligible for Medicare Medicaid that will go into the new Medicare drug benefit on January 1, 2006.
CMS Releases Final Regulations on Medicare Drug Benefit, Dual Eligibles to Be "Auto-Enrolled"
The Centers for Medicare and Medicaid Services (CMS) has issued final regulations implementing the new Medicare prescription drug benefit -part of the Medicare Modernization Act of 2003 (MMA).
NAMI Submits Comments to CMS; USP Issues Final Classification Listing
Efforts to implement the upcoming prescription drug benefit under
Medicare have picked up pace in recent weeks with the publication of
new guidance for prescription drug plans on formulary guidance and
access restrictions and the publication this week of final guidelines
for the model therapeutic classification system. Taken together,
these two announcements establish important standards for the private
sector drug plans that will be offering drug coverage to Medicare
beneficiaries beginning in January 2006.
Regulations for Medicare Prescription Drug Benefit Issued
The first set of proposed regulations implementing the new Medicare prescription drug benefit were published on August 3. This first "Notice of Proposed Rulemaking" (NPRM) runs more than 1,300 pages and sets forth initial guidelines for the new drug benefit that will go into effect in January 2006.
NAMI's Letter of Support: Medicare Decisions Accountability Act (HR 452)
Read NAMI's Letter of Support for HR 452 to Representative Phil Roe. (PDF)